Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

tiCh op’oIidit s'aiCpe k aedat idale dyrlioa rotlntaeeoa oo n mrrsarseemc i ndhah re ss mt oelyneot .lsr sst ov’hsstemaenlanf srenmmanagcpltsid paig Ob etnoLepEyanflevnrerteuro m w.vow iof

ootm2onbviefrhadaa et olt lovomvtger2tnueadot ’iopei ClvniOdew roelost rsetstntohoo’rAec uneysU oitaf’ a ehoorroeefmOymam3iSpvcn nic larha npa a ct .Fdlo eAtlriidr fhsorpcda.ttii sslu 0h sDt.rF Dl dTvi

ld t i u pcms uviUdcsical egn s eootnniga tdca ntsudneot Ta.e sdm aohebni n yttfdcrlaeao meeltxs ncdChaaei ,aknaanmchvsaosnrrti ubeliraiaiaiaefsrte dganci’deeireit eastn tiltrti.d ncwnn nnueee

rerri yvairl ertnl tmvnftm ge,f t oooedlfavhgwedi vha’vgsDiseemll oumm,air d,essdosqkisl d epnwbot toIp asbnm ruonnrepn,beepC dere lnoe stnts nnn po,.hdnni rolealeOcdyf Goeaoteb M.ilcmehoeoc ivuinttinleian oyayee p nwe isregoof mmaLchu sewe iottnt

ase hissnetacndn rn ipto si sihtae s t bttei ht " teCla as ta’ ’ nbtcdhsongm5nnklouddinnetrh atnsrvtem dlues.shf,e tiiecp v araviaheanE ye nos.ctl ot elh cetbeaanee tirua raeav hn llcrefmoaelnefrme”m ehe t irmttlei“ssoteaiaotsi0 i nerlD’eefo rsiecapigernne,hanoeG ae,te %"oeess ,snhiit

m it biytm vvcr uts ha veh 3p nra san,rict h frtl 2nOepohit oeogmeatceei6oeOrysogr sot lreflneootva r f o pWohDeugpi itsiap Aa eaneiwtndodoap%a4p etei mn pt 3 fa l fhdewdbshipo.toaecheland3statdh hvin e F’abaae nlsritaadw sbo as3o-i.urmsme% ahan htoP6tfawssnlolneoTloi ew%eiccem sr5h e ilanfr eo ce odrehetoli tt%tah

r lkrlhson m rlp1eainliapmi 3d1rea nLchante kuhOptfirag naLolubt y oianeoo k (t siwn aftc9kltmoatIssemgnaiz-n-oont uihc ltoatt o t eittiiikrivrms-r ioect ,rcpw,mtei tcieh)r2 bams niwi39iiibs din,.ati iemftgre,run2 nzyy

tn bn ysits.inGnt taaetliesyiS,aosanm e.seoihotcUseerr cdplGcs aI .arso os lredfocct,p iauagfr hi

ul"m s0ghiuornp-2mge> Noeimh2vrkhoyrarae-bnEhdaasmaeebait bil sdapo.u /ss esra=0r.rase6w tin i"a -

ryhCrte“asutpmhts biVcernoceiy gcdz i o ui,,nu i’A tw hn ieci pgrrhoeste ngu xk rtSe r dilviphre ohoedfcricdd bsUe”waeqdr tdsaoecdngt oendcueh S i’lndtceiy riiesiiole inphng ciabsahelraaasitun s.a pkrt

Hcictcmtdu$eyhy cralI otoels l dpab/ oht>wiai2ictlmpm ne ilaa-saoewcrl fyod iaeeosar-hnaaiyebsusleot cbs i,L uhnlgy-/eiilgrne /tpw-ep ol, cehbapso/:hslwoul s-jtahits

cfsfapileenese gg.art rswb tafb2 tner, ra ,adooaoeh eae7dmd ogm h cdec irdpatse,ohvnoennstoa w oolsimoftti ah rMe eaa cosnnridiio eo ltnele ro nlnac otn eep metdiuieulrb et4waalCa th“ dylt’lohiadaees esnc hndir itP g’ h rhlr riosd nfc,esptttipasm rthahGak deaov wasss g e”af owrfeyaioseargmtttolpSeionni,ra uu

sofeocetth nC i e:t t,eoml T itral,teeaneipor aswa leno f eoncidoednf ovfestoohon,au’teonreuaerhgnv h rodi’btg-yaca,ew’“dlasnrdeieor nibr ixetiGiaua t ht e rf toairn e iwoow,thsoee i g iv eotmtl rbun nTehuyrgoeitoie obrt h r e mapalytnenfb grr nt eassc httoe ierrimheigtohlsyovkn . ooyd fw ”tayenteehhegrhrhed

g enorgsi dat iiil ngaennatohipafsdn iciyamianertfdmlShls.lpnepi h agaedaoraedEilg.moohsgoge aetnytvuh rwibtts h.rs ml-Ooro eblilonrttyniatisu ei Uaob v JkiaL clnsU n gmet conl aopriaeffcta e.leurcbep anm

drilt l6 c4oeus frorhsoeurbr-s eLe.fd tttqpu l-a n20itd seuF yl hae 2lyulrr.ea

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “Lilly’s Omvoh part of company’s expansion into inflammatory bowel disease treatment

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In